FDA Warns AstraZeneca on ' Misleading Claims ' About COPD Drug FDA Warns AstraZeneca on ' Misleading Claims ' About COPD Drug

Claims that Breztri has been shown to reduce risk of death in COPD patients are not supported by clinical data, the agency says.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news